FDA Examines Process For Approving Ebola Vaccine In Light Of Waning Outbreak

CQ HealthBeat: FDA Weighs Process for Approving Ebola Vaccine
“A Food and Drug Administration advisory panel on Tuesday tackled difficult questions on the development of a vaccine for the Ebola virus although the outbreak, which has killed more than 11,000 people, has subsided. … While that comes as good news for public health, it presents a challenge for drug development and for regulators who now need to look at other data, potentially from animal studies, as it reviews potential vaccines…” (Gustin, 5/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.